One Dose of LSD Med Yields Rapid, Durable Response for GAD

A single oral administration of MM120 (lysergide d-tartrate), an investigational lysergic acid diethylamide (LSD)–based medicine being developed by Mind Medicine Inc (MindMed), provided rapid and durable improvement in generalized anxiety disorder (GAD) in a phase 2B study.  At 12 weeks, 65% of patients treated with MM120 100 µg had a clinical response…

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button